GLORIANNA ILOFF: Open Payments
NPI 1285926063 · BENBROOK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 78 payments from 17 companies in 2025. Trend: 2023 $1,467 · 2024 $1,099 · 2025 $1,662
Food & beverage: $1,578Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $482 |
| Janssen Biotech, Inc. | 10 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $240 |
| Madrigal Pharmaceuticals | 5 | $132 |
| Ipsen Biopharmaceuticals, Inc | 4 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $114 |
| Aimmune Therapeutics, Inc. | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $36 |
| Gilead Sciences, Inc. | 1 | $34 |
Products named: RINVOQ, TREMFYA, SKYRIZI, ENTYVIO, REZDIFFRA, IQIRVO, XIFAXAN, ZENPEP.
Industry payments across TX — which companies pay providers there.
